180 related articles for article (PubMed ID: 21044078)
1. α-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential.
Lichtenthaler SF
J Neurochem; 2011 Jan; 116(1):10-21. PubMed ID: 21044078
[TBL] [Abstract][Full Text] [Related]
2. Alpha-secretase cleavage of the amyloid precursor protein: proteolysis regulated by signaling pathways and protein trafficking.
Lichtenthaler SF
Curr Alzheimer Res; 2012 Feb; 9(2):165-77. PubMed ID: 21605033
[TBL] [Abstract][Full Text] [Related]
3. Alpha-secretase activation--an approach to Alzheimer's disease therapy.
Fahrenholz F; Postina R
Neurodegener Dis; 2006; 3(4-5):255-61. PubMed ID: 17047365
[TBL] [Abstract][Full Text] [Related]
4. Ectodomain shedding of the amyloid precursor protein: cellular control mechanisms and novel modifiers.
Lichtenthaler SF
Neurodegener Dis; 2006; 3(4-5):262-9. PubMed ID: 17047366
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.
Parvathy S; Ehrlich M; Pedrini S; Diaz N; Refolo L; Buxbaum JD; Bogush A; Petanceska S; Gandy S
J Neurochem; 2004 Aug; 90(4):1005-10. PubMed ID: 15287907
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells.
Parvathy S; Hussain I; Karran EH; Turner AJ; Hooper NM
Biochemistry; 1999 Jul; 38(30):9728-34. PubMed ID: 10423252
[TBL] [Abstract][Full Text] [Related]
8. Secretase inhibitors and modulators for Alzheimer's disease treatment.
Tomita T
Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
[TBL] [Abstract][Full Text] [Related]
9. Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently.
Fu H; Dou J; Li W; Cui W; Mak S; Hu Q; Luo J; Lam CS; Pang Y; Youdim MB; Han Y
Eur J Pharmacol; 2009 Nov; 623(1-3):14-21. PubMed ID: 19765582
[TBL] [Abstract][Full Text] [Related]
10. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons.
Kuhn PH; Wang H; Dislich B; Colombo A; Zeitschel U; Ellwart JW; Kremmer E; Rossner S; Lichtenthaler SF
EMBO J; 2010 Sep; 29(17):3020-32. PubMed ID: 20676056
[TBL] [Abstract][Full Text] [Related]
11. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.
Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT
Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131
[TBL] [Abstract][Full Text] [Related]
12. Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C ε-mediated metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model.
Zara S; Rapino M; Sozio P; Di Stefano A; Nasuti C; Cataldi A
Brain Res; 2011 Sep; 1412():79-87. PubMed ID: 21820649
[TBL] [Abstract][Full Text] [Related]
13. Activation of α7 nicotinic receptor affects APP processing by regulating secretase activity in SH-EP1-α7 nAChR-hAPP695 cells.
Nie HZ; Shi S; Lukas RJ; Zhao WJ; Sun YN; Yin M
Brain Res; 2010 Oct; 1356():112-20. PubMed ID: 20708605
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.
Wang YQ; Qu DH; Wang K
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2389-403. PubMed ID: 27338066
[TBL] [Abstract][Full Text] [Related]
15. Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease.
Johnston JA; Liu WW; Todd SA; Coulson DT; Murphy S; Irvine GB; Passmore AP
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1096-100. PubMed ID: 16246054
[TBL] [Abstract][Full Text] [Related]
16. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
17. Activation of the α-secretase processing of AβPP as a therapeutic approach in Alzheimer's disease.
Vincent B; Govitrapong P
J Alzheimers Dis; 2011; 24 Suppl 2():75-94. PubMed ID: 21422515
[TBL] [Abstract][Full Text] [Related]
18. New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity.
Yang HQ; Pan J; Ba MW; Sun ZK; Ma GZ; Lu GQ; Xiao Q; Chen SD
Eur J Neurosci; 2007 Jul; 26(2):381-91. PubMed ID: 17650113
[TBL] [Abstract][Full Text] [Related]
19. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
Yan R; Bienkowski MJ; Shuck ME; Miao H; Tory MC; Pauley AM; Brashier JR; Stratman NC; Mathews WR; Buhl AE; Carter DB; Tomasselli AG; Parodi LA; Heinrikson RL; Gurney ME
Nature; 1999 Dec; 402(6761):533-7. PubMed ID: 10591213
[TBL] [Abstract][Full Text] [Related]
20. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.
Sun X; Wang Y; Qing H; Christensen MA; Liu Y; Zhou W; Tong Y; Xiao C; Huang Y; Zhang S; Liu X; Song W
FASEB J; 2005 May; 19(7):739-49. PubMed ID: 15857888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
